Clinical Trials Present Better Alternatives for Dialysis PatientsSeptember 13, 2007CINCINNATI-Having a healthy kidney is worth a billion dollars. But an unhealthy kidney costs more-about $16 billion more, according to Prabir Roy-Chaudhury, MD, PhD, associate professor in the division of nephrology and hypertension at the University of Cincinnati (UC). "It costs about $17 billion a year to care for patients with end-stage kidney disease," he said.
There are currently over 320,000 people undergoing hemodialysis in the United States, a process that costs taxpayers a minimum of $60,000 per patient annually, Hemodialysis is a technique in which a machine filters wastes out of a patient's blood once the kidney fails. "In order to perform successful dialysis, it's critical to have a functioning vascular access," Roy-Chaudhury said. There are two main types of permanent dialysis access: an arteriovenous fistula, which connects the artery and the vein directly, and an arteriovenous graft, which connects the artery and the vein using a plastic tube. Unfortunately, these connections may only last between six and 12 months due to stenosis, or narrowing of the veins. As a result, hemodialysis patients often have repeated hospital admissions and surgeries in order to keep their dialysis access open. In fact, problems associated with vascular access are probably the biggest factors that reduce the quality of life for hemodialysis patients, Roy-Chaudhury said. "Hemodialysis vascular access dysfunction is viewed as the Achilles heel of dialysis," he added. In order to reduce the problems linked with hemodialysis vascular-access dysfunction, Roy-Chaudhury, UC surgeons Rino Munda, MD, and Steve Woodle, MD, and colleagues in engineering, radiology, cardiology and pathology have established the Cincinnati Dialysis Access Research Program (CAP). CAP is a multidisciplinary program that includes NIH-funded basic science research, industry- funded animal studies of new devices and clinical trials for the treatment and prevention of dialysis access stenosis. Some of the clinical trials being conducted by UC's division of nephrology and transplant surgery include the use of medicated wraps, placed around the access area at the time of surgery. Others include special balloons that allow physicians to deliver a drug directly to the outside of the vessel wall following expansion of the vessel. "The mission of the CAP is to improve the quality of life for dialysis patients by reducing the problems associated with dialysis vascular access," said Roy-Chaudhury. "We also believe that we can save taxpayers money through our application of cutting-edge technology." "The fact that we have different specialists working on the same project is a huge strength and a credit to the research atmosphere at UC." University of Cincinnati Science News and Science Current Events Tag Cloud This tag cloud is a visual representation of term frequencies of random science news topics with common terms grouped together and emphasized by their display size. Snoring Migraine Hodgkin Lymphoma Breast Cancer Behavioral Problems Protein Avian Flu Angiography Adult Stem Cells Particle Accelerator Enceladus Data Storage Circumcision Quantum Physics Pre-eclampsia Blood Pressure Sea Turtles Biology Cirrhosis Rem Sleep Polymer Diatoms Testicular Cancer Child Care Cox-2 Inhibitors
See More: Science News Tags | |||||||||||||||||||||
|
Related Dialysis Current Events and Dialysis News Articles Older kidney transplant patients should more often consider live donors Almost half of kidney transplant candidates older than 60 who are put on the waiting list for a deceased-donor organ will die before getting a transplant. Combination of aspirin and an anti-clotting drug reduces risk of dialysis access failure For the first time, a combination of aspirin and the anti-platelet drug dipyridamole has been shown to significantly reduce blockages and extend the useful life of new artery-vein access grafts used for hemodialysis, according to a study by the Dialysis Access Consortium (DAC). Study finds novel genetic risk factors for kidney disease A team of researchers from the United States, the Netherlands and Iceland has identified three genes containing common mutations that are associated with altered kidney disease risk. Chemical can reproduce complications for some patients Medical science took a giant leap forward with the development of techniques that, at least temporarily, perform the function of vital organs. Chemical found in medical devices impairs heart function Researchers at the Johns Hopkins University School of Medicine have found that a chemical commonly used in the production of such medical plastic devices as intravenous (IV) bags and catheters can impair heart function in rats. Does a person's insurance coverage affect their access to quality cancer care? Does a person's insurance coverage affect their access to quality cancer care? According to researchers at Fox Chase Cancer Center, insurance coverage may not only affect a patient's access to health care, but also the quality of care they receive. Robotic assisted kidney cancer surgery proves to be beneficial to patients Fox Chase Cancer Center researchers find that outcomes of robotic assisted kidney cancer surgery, when performed by experienced surgeons at high volume centers, prove more beneficial to patients when compared to open surgery. 'Nature vs. nurture' study of deceased donor pairs in kidney transplantation The implications of a new study could improve the outcomes, and potentially survival rates, for some of the thousands of individuals who undergo kidney transplants each year. Proteins from garden pea may help fight high blood pressure, kidney disease Researchers in Canada are reporting that proteins found in a common garden pea show promise as a natural food additive or new dietary supplement for fighting high blood pressure and chronic kidney disease (CKD). Those potentially life-threatening conditions affect millions of people worldwide. For old or young dialysis patients, AV fistulas remain pure gold A new study shows that for those individuals with chronic kidney disease, it doesn't matter if you're young or old: arteriovenous (AV) fistulas remain the gold standard for maintaining access to one's circulatory system to provide life-sustaining dialysis. More Dialysis Current Events and Dialysis News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||